TY  - GEN
AU  - Klein,Oliver
AU  - Davis,Ian D
AU  - McArthur,Grant A
AU  - Chen,Li
AU  - Haydon,Andrew
AU  - Parente,Phillip
AU  - Dimopoulos,Nektaria
AU  - Jackson,Heather
AU  - Xiao,Kun
AU  - Maraskovsky,Eugene
AU  - Hopkins,Wendie
AU  - Stan,Rodica
AU  - Chen,Weisan
AU  - Cebon,Jonathan
TI  - Low-dose cyclophosphamide enhances antigen-specific CD4(+) T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanoma
SN  - 1432-0851
PY  - 2015///0521
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antigens, Neoplasm
KW  - immunology
KW  - Antineoplastic Agents, Alkylating
KW  - administration & dosage
KW  - CD4-Positive T-Lymphocytes
KW  - Cancer Vaccines
KW  - Cholesterol
KW  - Cohort Studies
KW  - Combined Modality Therapy
KW  - Cyclophosphamide
KW  - Dose-Response Relationship, Drug
KW  - Drug Combinations
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Lymphatic Metastasis
KW  - Male
KW  - Melanoma
KW  - Membrane Proteins
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Phospholipids
KW  - Prognosis
KW  - Saponins
KW  - T-Lymphocytes, Regulatory
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1007/s00262-015-1656-x
ER  -